---
title: Validation and clinical performance of a single test, DNA based endometrial
  cancer molecular classifier
date: '2024-10-26'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39461743/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241027204039&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: External validation confirmed that single test, DNA based
  molecular classification was highly concordant (95%) with original ProMisE classification,
  with prognostic value maintained, representing an acceptable alternative for clinical
  practice. Careful consideration of reasons for discordance and knowledge of how
  to correctly assign multiple classifier endometrial cancers is imperative for ...'
disable_comments: true
---
CONCLUSION: External validation confirmed that single test, DNA based molecular classification was highly concordant (95%) with original ProMisE classification, with prognostic value maintained, representing an acceptable alternative for clinical practice. Careful consideration of reasons for discordance and knowledge of how to correctly assign multiple classifier endometrial cancers is imperative for ...